Fig. 2From: Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)Comparison of value contribution of each criterion: alpha – 1 antitrypsin, tolvaptan and eliglustat. PRO: Patient Reported OutcomesBack to article page